NASDAQ Companies

StemPrintER Outperforms Oncotype DX in analysis with 800+ samples from ER+/HER2- postmenopausal breast cancer patientsSPARE Model is up to 40-50% […]

— First NDA filing of savolitinib globally ——  Chi-Med seeking first-in-class Chinese marketing authorization for a selective MET inhibitor —LONDON, May 29, 2020 (GLOBE [...]

Geneva, Switzerland and Boston, MA – May 29, 2020 – ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company developing and […]

SHANGHAI, China, May 28, 2020 (GLOBE NEWSWIRE) — Qutoutiao Inc. (“Qutoutiao” or the “Company”) (NASDAQ: QTT), a leading operator of […]

SAN CARLOS, Calif., May 28, 2020 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (Nasdaq:IOVA) (“Iovance” or “Company”), a late-stage biotechnology company developing […]

CHAMPAIGN, Ill., May 28, 2020 (GLOBE NEWSWIRE) — First Busey Corporation (NASDAQ: BUSE) (the “Company”), the holding company for Busey Bank […]

LAKE FOREST, Calif, May 28, 2020 (GLOBE NEWSWIRE) — ToughBuilt Industries, Inc. (“ToughBuilt” or the “Company”) (NASDAQ: TBLT; TBLTW), an […]

MELBOURNE, Australia, May 28, 2020 (GLOBE NEWSWIRE) — Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in […]

SYDNEY, Australia, May 29, 2020 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep“ or “the Company”), a biotechnology […]

NOVA LIMA, Brazil, May 28, 2020 (GLOBE NEWSWIRE) — Afya Limited (Nasdaq: AFYA) (“Afya” or the “Company”), the leading medical […]